Drug · DIN 02517868
ARAZLO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 16, 2021; first marketed September 16, 2021.
- Drug Identification Number (DIN)
- 02517868
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Lotion
- Route
- Topical
- Therapeutic class (ATC)
- Tazarotene D05AX05
- Class
- Human
- Record last updated
- January 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TAZAROTENE | 0.045 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 8, 2021: NOC 26223New Drug Submission (NDS)